June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Safety of Intravitreal Injections Performed by Ophthalmology Residents
Author Affiliations & Notes
  • Ravi Patel
    Ophthalmology, Hershey Medical Center, Hummelstown, PA
  • Jason R Mayer
    Ophthalmology, Hershey Medical Center, Hummelstown, PA
  • Christopher Weller
    Ophthalmology, Hershey Medical Center, Hummelstown, PA
  • Ingrid U Scott
    Ophthalmology, Hershey Medical Center, Hummelstown, PA
  • David A Quillen
    Ophthalmology, Hershey Medical Center, Hummelstown, PA
  • Footnotes
    Commercial Relationships Ravi Patel, None; Jason Mayer, None; Christopher Weller, None; Ingrid Scott, None; David Quillen, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4177. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ravi Patel, Jason R Mayer, Christopher Weller, Ingrid U Scott, David A Quillen; Safety of Intravitreal Injections Performed by Ophthalmology Residents. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4177.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To investigate the safety profile of intravitreal injections performed by ophthalmology residents.

 
Methods
 

Retrospective consecutive series of 500 intravitreal injections performed between September 2009 and March 2014 at the Lebanon Veterans Affairs Medical Center by ophthalmology residents for patients with neovascular age related macular degeneration (AMD), diabetic macular edema (DME), or macular edema associated with retinal vein occlusion.<br />

 
Results
 

No patient in this study developed endophthalmitis, traumatic cataract, uveitis, retinal tears, vitreous hemorrhage or retinal detachments. Three patients (2.4%) with preoperative pigment epithelial detachments developed retinal pigment epithelial tears (RPE) following intravitreal injection. All three patients developed RPE tears within 3 months of receiving intravitreal injection. These results are similar to those reported in the literature.

 
Conclusions
 

Results of this study suggest that, with appropriate training and supervision, ophthalmology residents can perform intravitreal injections with a similar safety profile to that reported in series of intravitreal injections performed by retina specialists. Larger studies are warranted to confirm these preliminary findings.  

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×